Aviral Jain

1.6k citations
49 papers · 1.2k indexed · h-index 20

Aviral Jain

46 papers receiving 1.1k citations

Peers

Aviral Jain
Comparison fields: 5 of 116
  • Pharmaceutical Science 483
  • Biomaterials 372
  • Molecular Medicine 72
  • Food Science 134
  • Molecular Biology 388
Replace Anekant Jain with:
Anekant Jain India
Emad B. Basalious Egypt
Raida Al‐Kassas New Zealand
Omathanu Perumal United States
Tobias Jung Germany
Vivek Dhawan India
Dengning Xia China
Abhay Asthana India
Sanaa A. El‐Gizawy Egypt
Jiabi Zhu China
Aviral Jain relative to Anekant Jain India Anekant Jain's profile →
Citations per field
00.5×1.5×
Anekant Jain · 1×
Citations per year

Countries citing papers authored by Aviral Jain

Since Specialization
Citations

This map shows the geographic impact of Aviral Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aviral Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aviral Jain more than expected).

Fields of papers citing papers by Aviral Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aviral Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aviral Jain. The network helps show where Aviral Jain may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aviral Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aviral Jain Line = papers co-authored together Aviral Jain links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201412
2 201434
3 201325
4 201314
5 201113
6 201126
7 201028
8 201043
9 200924
10 20094
11 200920
12 2008113
13 2008154
14 200822
15 20078
16 2006131
17 200558
18
Novel Approaches For Drug Delivery To The Brain
20047
19 200334
20 19722

About Aviral Jain

Aviral Jain is a scholar working on Pharmaceutical Science, Biomaterials and Food Science, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (17 papers), Nanoparticle-Based Drug Delivery (14 papers), RNA Interference and Gene Delivery (13 papers), Advancements in Transdermal Drug Delivery (9 papers), Lipid Membrane Structure and Behavior (9 papers), Drug Solubulity and Delivery Systems (6 papers), Graphene and Nanomaterials Applications (4 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Pharmaceutical Science (483 citations), Biomaterials (372 citations) and Molecular Medicine (72 citations). Aviral Jain has collaborated with scholars based in India and Switzerland. Frequent co-authors include Sanjay Jain, Arvind Gulbake, Piush Khare, Vandana Soni, Yashwant Gupta, Manish K. Chourasia, Satish Shilpi, Pooja Hurkat, Ashish Jain and Mohini Chaurasia. Their work appears in journals such as Critical Reviews in Therapeutic Drug Carrier Systems, Drug Delivery, Journal of Microencapsulation, Journal of Drug Delivery Science and Technology and Journal of Nanoparticle Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026